edit, sorry Senti this response was to iwasadiver's post you responded to.
"I just feel too many here are building up ASCO to be this big event and I simply don’t think that’s rational and I hate to see the fallout of a disappointed group of shareholders"
I am afraid this "fallout" will happen with some shareholders regardless. I don't believe it will necessarily be down to missing any ASCO deadline, but more about us passing 8+ month since Data lock. Unless the company provide a realistic timeline to TLD by ASCO it would not surprise me if we do see some degree of sell off. Of course many longs will 'stay the course' but not providing a credible plan along with continue silence could be too much for some.
It is intriguing however, that not only is LL presenting on the 18th May but that the title is "Brain tumor clinical trial update" Therefore, there is hope that we get TLD soon regardless of how they announce it. If we don't get news before the ASM, we would have to get it on the 18th prior to LL's talk if she intends to discuss results or unblinded data. Difficult to imagine she will just provide the same blinded updates we have had to date but who knows?
Virtual Visiting Professor: Brain Tumor Clinical Trial Update Tuesday, May 18, 6:00–7:00 pm CT Faculty: Amy Heimberger, Linda Liau, Ian Parney Moderator: Edjau Nduom
Market Data 
Markets 
AI
